Dr. Mailhot is an Associate Professor in the Department of Radiation Oncology at the University of Florida. He leads the University of Florida Hematologic Radiotherapy Program. He has published over 60 research articles in peer-reviewed medical journals and presented research at more than 40 national and international medical conferences. Community education is important to Dr. Mailhot, and he passionately shares his knowledge at many community events such as support groups and symposiums.

Dr. Indelicato is a tenured Professor and Associate Vice Chair of the University of Florida Department of Radiation Oncology. He currently holds the William and Joan Mendenhall Endowed Professorship of Pediatric Radiotherapy and directs the University of Florida pediatric radiotherapy program. He was named a Fellow of the British Royal College of Radiology in 2023 and a Fellow of the American Society of Radiation Oncology in 2024.

Dr. Roi Dagan is an Associate Professor in the Department of Radiation Oncology at the University of Florida College of Medicine. He completed his medical training and residency at the University of Florida, College of Medicine and was Chief Resident Physician from 2011-2012. Dr. Dagan is the physician lead for the head and neck program and the ocular tumor program at the UF Health Proton Therapy Institute.

Dr. Bryant is an Associate Professor of Radiation Oncology at the University Of Florida College Of Medicine. He has presented over 40 scientific and educational talks at national and international conferences. Dr. Bryant has published more than 40 peer-reviewed publications and 3 textbook chapters. He is part of the head and neck cancer team at the University of Florida that won the Top Team Effort Award in 2014 from the University of Florida Cancer Center. 

Dr. Julie Bradley is a Professor with tenure in the Department of Radiation Oncology at the University of Florida. With an intense focus on breast cancer and pediatric tumors in both the clinical and research realms, she possesses a deep knowledge of these cancer types and provides comprehensive, personalized care for people affected by these diagnoses.